MedPath
NMPA Approval

Dapagliflozin Tablets

国药准字H20249826

December 25, 2024

Drug Information

达格列净片

片剂

10mg(以C₂₁H₂₅ClO₆计)

化学药品

December 25, 2024

Company Information

Applicant Company

长沙市浏阳经济技术开发区健康大道1号

Manufacturing Company

长沙市浏阳经济技术开发区健康大道1号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

达格列净片 - NMPA 批准文号 | MedPath